Insulin glargine biosimilar - Boehringer Ingelheim/Eli Lilly and Company
At a glance
- Drug Originator Eli Lilly and Company
- Drug Licenced by Boehringer Ingelheim; Cipla
- Drug Class Antihyperglycaemics; Insulins; Pancreatic hormones
- Mechanism of Action Insulin receptor agonists; Ornithine decarboxylase stimulants; Phosphokinase stimulants; Protein tyrosine kinase stimulants
- USA Patent Applicants ELI LILLY AND CO
- USA Patents 127
- BLAs 1
- International Patents 1,793

Disclaimer